TGFB1 and pulmonary fibrosis: In summary, our results indicate that KFXOL inhibits the TGF-β/Smad signaling pathway, decreasing the differentiation, proliferation, and migration of fibroblasts, and decreasing ECM deposition, leading to an improvement in BLM-induced pulmonary fibrosis.